Materials
Specialty Chemicals
$23.63B
20K
Key insights and themes extracted from this filing
Revenues decreased by $805 million, or 2%, in 2024 compared to 2023. Lower average sales prices driven by lower demand resulted in a 2% decrease in revenues. This indicates pricing pressure in the market.
The company recognized non-cash impairment charges of $949 million in 2024, primarily related to property, plant, and equipment in the O&P-EAI and APS segments. This contrasts with $518 million in impairment charges in 2023, suggesting a deterioration in the value of certain assets.
Cash provided by operating activities was $3,819 million in 2024, only slightly reduced from $4,942 million in 2023. This indicates effective cash management and the ability to generate cash despite revenue headwinds.